The Masking Game: Design of Activatable Antibodies and Mimetics for Selective Therapeutics and Cell Control
Autor/a
Lucchi, Roberta
Bentanachs, Jordi
Oller Salvia, Benjamí
Otros/as autores/as
Universitat Ramon Llull. IQS
Fecha de publicación
2021-04-26ISSN
2374-7951
Resumen
The high selectivity and affinity of antibody binding havemade antibodies all-pervasive tools in therapy, diagnosis, and basic science.A plethora of chemogenetic approaches has been devised to makeantibodies responsive to stimuli ranging from light to enzymatic activity,temperature, pH, ions, and effector molecules. Within a single decade, thefield of activatable antibodies has yielded marketed therapeutics capable ofengaging antigens that could not be targeted with traditional antibodies, aswell as new tools to control intracellular protein location and investigatebiological processes. Many opportunities remain untapped, waiting formore efficient and generally applicable masking strategies to be developedat the interface between chemistry and biotechnology
Tipo de documento
Artículo
Versión del documento
Versión publicada
Lengua
English
Materias (CDU)
616 - Patología. Medicina clínica. Oncología
Palabras clave
Antigens
Biopolymers
Cancer therapy
Immunology
Peptides and proteins
Antígens
Biopolímers
Càncer--Tractament
Immunologia
Pèptids
Proteïnes
Páginas
15 p.
Publicado por
American Chemical Society
Publicado en
ACS Central Science
Número del acuerdo de la subvención
info:eu-repo/grantAgreement/EC/Grant No.844441
info:eu-repo/grantAgreement/MCIU/FPU19/03216
info:eu-repo/grantAgreement/SUR del DEC/SGR/SGR 2017 1559
Este ítem aparece en la(s) siguiente(s) colección(ones)
Derechos
© L'autor/a
Excepto si se señala otra cosa, la licencia del ítem se describe como http://creativecommons.org/licenses/by-nc/4.0/